Captrust Financial Advisors Raises Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Captrust Financial Advisors grew its holdings in Azenta, Inc. (NASDAQ:AZTA) by 22.1% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,179 shares of the company’s stock after buying an additional 2,026 shares during the period. Captrust Financial Advisors’ holdings in Azenta were worth $559,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in AZTA. Assenagon Asset Management S.A. purchased a new position in shares of Azenta in the 4th quarter worth $200,000. Ballentine Partners LLC boosted its stake in shares of Azenta by 2.0% during the 4th quarter. Ballentine Partners LLC now owns 20,340 shares of the company’s stock worth $1,017,000 after purchasing an additional 404 shares during the period. SG Americas Securities LLC purchased a new position in shares of Azenta during the 4th quarter worth about $813,000. Exchange Traded Concepts LLC boosted its stake in shares of Azenta by 7.3% during the 4th quarter. Exchange Traded Concepts LLC now owns 375,627 shares of the company’s stock worth $18,781,000 after purchasing an additional 25,545 shares during the period. Finally, KBC Group NV boosted its stake in shares of Azenta by 48.5% during the 4th quarter. KBC Group NV now owns 2,137 shares of the company’s stock worth $107,000 after purchasing an additional 698 shares during the period. 99.08% of the stock is owned by hedge funds and other institutional investors.

Azenta Price Performance

Shares of AZTA opened at $27.47 on Monday. Azenta, Inc. has a 1-year low of $23.91 and a 1-year high of $63.58. The company has a 50-day moving average of $30.00 and a 200 day moving average of $41.54. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of -9.22 and a beta of 1.64.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. During the same quarter in the prior year, the business posted $0.06 EPS. The business’s revenue for the quarter was up 5.1% compared to the same quarter last year. On average, equities analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts recently commented on AZTA shares. Evercore ISI lifted their price target on shares of Azenta from $50.00 to $52.00 and gave the stock an “in-line” rating in a research note on Thursday, February 6th. Needham & Company LLC dropped their price target on shares of Azenta from $59.00 to $40.00 and set a “buy” rating for the company in a research note on Wednesday, May 7th. Finally, TD Cowen raised shares of Azenta to a “hold” rating in a research note on Thursday, February 27th.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.